Global Insights Local Impact
The ImmunoACT team that worked on India’s first approved CAR-T therapy NexCAR 19; image courtesy: ImmunoACT Synopsis NexCAR 19, India’s first cell therapy to treat a specific form of blood cancer, is showing encouraging results. Now listed at 40 hospitals across the country, its indigenous maker, ImmunoACT, is driving a medical revolution. Can the battle
Read More
Rajeev Juneja, vice-chairman and managing director, Mankind Pharma; image credit: Company Synopsis While Ramesh Juneja has led Mankind Pharma for three decades, his brother Rajeev kept in tow and took charge of key operations. Suave and yet rustic, the younger Juneja has a unique style to push the 12,000-strong team of medical representatives in a
Read More
Illustration by Sadhana Saxena via AI Synopsis The recent successes of leading pharmaceutical products show that drug companies have been plain lucky to hit the jackpot. While long-term strategies continue to be important, drug makers have often struck gold with pipeline compounds that they had once simply dumped. Does serendipity help pharmaceutical companies rake in
Read More
Maziar Mike Doustdar, executive VP, Novo Nordisk; image credit: Company Synopsis Novo Nordisk, the most valuable pharmaceutical company in the world, turned 100 last year. While it is largely known for its insulins, its anti-obesity drugs are making waves of late. Maziar Mike Doustdar, executive vice-president, international operations at Novo Nordisk tells ET Prime the
Read More
India’s smaller cities and hinterland remain a neglected lot even as five-star specialty hospitals flourish in the metros. To have its healthcare parameters on track, India needs an urgent flow of investments in tertiary-care hospitals in tier-II and tier-III cities. But building and managing tertiary-care hospitals isn’t easy. Examples like Ujala Cygnus can show the
Read More
Last week, Global Health Ltd, the company which operates hospitals under the brand Medanta, made a strong debut on the Indian stock exchanges. Its shares gained 19% on the listing day. At Thursday’s close of INR462.50 per share, the stock is around 38% up from its issue price of INR336. The company’s initial public offering
Read More
A sharp surge in the number of diabetes patients, 77 million and counting, has turned India into a hotspot for deals to buy or sell prestigious medicine brands to treat the chronic disease. In the latest move, the USD60 billion drug giant Merck, known as MSD in India, has decided to put its iconic anti-diabetes
Read More
Epidemic control workers wear PPE as they wait to remove medical waste from apartments where people who have tested positive are doing home quarantine on December 6, 2022 in Beijing, China. Synopsis In many ways, China has become a victim of its own success. Tough countermeasures helped it cope with the early waves of the
Read More
Nandini Piramal, chairperson, Piramal Pharma; image courtesy of Piramal Pharma. Synopsis Piramal Pharma’s management is optimistic that with revenue growth and margin expansion, it will be able to trim debt over the next five years. But the capital-intensive nature of its main contract manufacturing business scaling remains a challenge. Will Piramal Pharma be able to
Read More
An Indian nurse (L) collects a blood sample from a policeman using a glucometer at a free diabetic health check-up camp on World Health Day in Hyderabad on April 7, 2016. Synopsis India nurses the second highest number of diabetics in the world. For most diabetics, fighting the slow-killer disease involves sticking to pills for
Read More